Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEFFE in Pulmonary Fibrosis
NCT05883293Phase 1Active, not recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Aug 2023
- Primary completion
- Aug 2026
- Modality
- Biologic, CFT (Cell-free therapy)
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Cell-free fat extract in pulmonary fibrosis (PF), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Modified UK Medical Research Council Respiratory Questionnaire at 12 months, Borg grading scale at 12 months and 1 more. Started Aug 2023; status: active, not recruiting.
02
Drugs
Cell-free fat extract
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT05883293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05883293.